Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck
Pharma
Failed Trodelvy first-line NSCLC trial shows better China data
Trodelvy-Keytruda showed a negative overall survival signal over Keytruda in the global phase 3 trial but a 35% positive trend in Chinese patients.
Angus Liu
Sep 12, 2026 9:45pm
FDA approves label expansion for PharmaEssentia's Besremi
Aug 31, 2026 8:25am
Courts reject Medicare price negotiation lawsuits from Merck, AZ
Aug 24, 2026 3:47pm
FDA approves an oral PCSK9 med for 1st time in Merck's Lipfendra
Jul 16, 2026 9:30am
Merck touts Keytruda front-line win in endometrial cancer subtype
Jul 15, 2026 3:33pm
Merck-Gilead first-of-its-kind combo pill scores in 2 HIV trials
Jun 9, 2026 11:20am
